Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering ...

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug ...

The chief executive of the Cambridge-headquartered pharmaceutical giant AstraZeneca has urged the European Union to allow the ...

in Sweden; and as part of a $500 million investment in a new facility in England. AstraZeneca has been under the direction of ...

Reported EPS is $1.3, expectations were $1.1. Andy Barnett - Head of IR: Pascal Soriot - Executive Director and CEO: Aradhana Sarin - Executive Director and CFO: Dave Fredrickson - EVP ...

AZ has already thrown down a marker for its tougher stance on Europe, with an earlier decision to abandon a $560 million ...

Pascal Soriot, CEO of AZ, said, “We cannot invest in every field,” adding, “It is better for specialized corporations to manage the central nervous system (CNS) area.” AZ is also ...

Astrazeneca's boss has warned Europe is falling behind as it steps up investment in the United States. Pascal Soriot said innovation in pharmaceuticals ‘has mostly been funded by the US’ as he doubled ...

European stocks closed higher on Wednesday, as investors pored through another slew of earnings and reacted to ...

Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US. Albery Bourla said there could be "tremendous investments" in R&D and manufacturing in the US.